Phibro Animal Health (PAHC) Finished Goods (2013 - 2026)

Phibro Animal Health's Finished Goods history runs 14 years deep, the most recent figure standing at $318.0 million for Q1 2026.

• On a quarterly basis, Finished Goods rose 17.67% year-over-year to $318.0 million in Q1 2026; TTM through Mar 2026 was $318.0 million, a 17.67% increase from a year earlier, with the FY2025 full-year figure at $253.8 million, up 49.69% from the prior year.
• Finished Goods rose to $318.0 million in Q1 2026 per PAHC's latest filing, from $309.7 million in the prior quarter.
• Across five years, Finished Goods topped out at $318.0 million in Q1 2026 and bottomed at $151.8 million in Q1 2022.
• The 5-year median for Finished Goods is $180.5 million (2024), against an average of $209.9 million.
• Across the five-year window, Finished Goods declined 3.0% in 2024 and surged 63.76% in 2025, its largest moves.
• Year by year, Finished Goods stood at $172.4 million in 2022, then rose by 7.05% to $184.6 million in 2023, then surged by 38.16% to $255.0 million in 2024, then gained by 21.43% to $309.7 million in 2025, then grew by 2.7% to $318.0 million in 2026.
• Per Business Quant, the three latest PAHC Finished Goods figures stand at $318.0 million (Q1 2026), $309.7 million (Q4 2025), and $279.6 million (Q3 2025).